Generated by AI
Teleflex Incorporated is a global medical technology company that designs, develops, manufactures, and supplies single-use devices used in critical care, surgery, and other hospital procedures. Teleflex Incorporated’s portfolio spans vascular access, anesthesia, emergency medicine, interventional cardiology and radiology, surgical applications, respiratory care, and urology, serving hospitals, healthcare providers, and medical device partners. The company also provides original equipment manufacturing services, supporting other medical device makers with components and specialized products. Its offerings are used in diagnostic and therapeutic procedures that require reliable, procedure-focused tools across a broad range of clinical settings. Headquartered in Wayne, Pennsylvania and founded in 1943, Teleflex Incorporated operates as a diversified healthcare equipment provider with a strong presence across the Americas, EMEA, and Asia.
Website550 East Swedesford Road
Wayne, PA, 19087-1603
United States
The latest articles about TFX.
Teleflex reported third quarter 2026 sales of US$567.78 million and net income of US$927.43 million, raised full year GAAP EPS guidance, continued a sizeable buyback program, and affirmed a US$0.34 quarterly dividend payable on December 31, 2026. Management plans to keep directing excess cash toward share repurchases and potential tuck in acquisitions that align with its three core businesses, pairing this with R&D and CapEx investment to support the current transformation program. The next...
Summary of Jan 8's posts. Generated by AI.
No summary yet.
No summary yet.
Summary of May 3's posts. Generated by AI.
Summary of Dec 9's posts. Generated by AI.
Investors talking about TFX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.